Skip to main content

Find Clinical Trials

Home
Conditions
Intestinal Neoplasms

Clinical trial condition

Intestinal Neoplasms

Explore clinical trials studying Intestinal Neoplasms. Study availability and eligibility vary by location and protocol.

6,428 public trials 1,394 recruiting studies

Refine in advanced search Browse all conditions

Intestinal Neoplasms trial results

Terminated

A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer

NCT05328908

Conditions: Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +18 more
Locations: Local Institution - 0044 Springdale, Arkansas, United States

Local Institution - 0012 Los Angeles, California, United States

Local Institution - 0117 Norwich, Connecticut, United States

Local Institution - 0025 Miami, Florida, United States

View all 139 locations

View Trial Details

Terminated

A Study of IBI351 in Combination With Cetuximab in Subjects With KRAS G12C Mutated Metastatic Colorectal Cancer

NCT05497336

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations: The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Terminated

A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors

NCT05572684

Conditions: Adnexal Diseases, Advanced or Metastatic Solid Tumors, Cervical Cancer, +52 more
Locations: Arizona Oncology Associates Tucson, Arizona, United States

Rocky Mountain Cancer Centers Aurora, Colorado, United States

St. Elizabeth Edgewood Hospital Edgewood, Kentucky, United States

Ochsner Cancer Institute New Orleans, Louisiana, United States

View all 17 locations

View Trial Details

Suspended

Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

NCT06102902

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +12 more
Locations: UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States

Los Angeles General Medical Center Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States

View all 15 locations

View Trial Details

Withdrawn

IX001 TCR-T In the Treatment of Advanced Pancreatic Cancer and Colorectal Cancer Induced by KRAS Mutations

NCT06487377

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +14 more
Locations: Shanghai Pudong Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Withdrawn

xDRIVE in Metastatic Colorectal Cancer

NCT06929338

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +15 more
Locations: Not specified

View Trial Details

Withdrawn

CASCADE: Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV

NCT07090174

Conditions: Acquired Immunodeficiency Syndrome, Anal Cancer, Anus Diseases, +40 more
Locations: Weill Cornell Medical College New York, United States

Montefiore Medical Center/Albert Einstein College of Medicine The Bronx, New York, United States

University of Puerto Rico San Juan, Puerto Rico

View Trial Details

Withdrawn

Fruquintinib Combined With TAS-102 in Refractory Metastatic Colorectal Cancer

NCT06221423

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +11 more
Locations: Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details